|
JPS53117215A
(en)
*
|
1977-03-24 |
1978-10-13 |
Hideyoshi Morita |
Earthquakeeproof steel beam
|
|
ES482789A0
(es)
*
|
1978-08-25 |
1980-12-01 |
Thomae Gmbh Dr K |
Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
|
|
US4258185A
(en)
*
|
1978-10-17 |
1981-03-24 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridazinone compounds
|
|
DE2935359A1
(de)
*
|
1979-09-01 |
1981-03-26 |
Basf Ag, 67063 Ludwigshafen |
6-imidazolyl-3-hydrazino-pyridazine
|
|
DE3006671A1
(de)
*
|
1980-02-22 |
1981-08-27 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue benzoxazole, deren herstellung und deren verwendung als arzneumittel
|
|
US4699909A
(en)
*
|
1981-07-25 |
1987-10-13 |
Dr. Karl Thomae Gmbh |
Benzotriazolyl-4,5-dihydro-3(2H)-pyridazinones
|
|
DE3129447A1
(de)
*
|
1981-07-25 |
1983-02-10 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
"neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel"
|
|
ZA859091B
(en)
*
|
1984-12-24 |
1987-07-29 |
Warner Lambert Co |
Novel 6-substituted-2 (1h)-quinolinones and related compounds having use as cardiotonic,anti-hypertensive,and anti-thrombotic agents
|
|
US4840955A
(en)
*
|
1984-12-24 |
1989-06-20 |
Warner-Lambert Company |
6-substituted-2(1H)-quinolinones and related compounds having use as cardiotonic, antihypertensive, and antithrombotic agents
|
|
US4868300A
(en)
*
|
1985-11-22 |
1989-09-19 |
Rorer Pharmaceutical Corporation |
Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
|
|
US4725686A
(en)
*
|
1985-11-22 |
1988-02-16 |
William H. Rorer, Inc. |
Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses
|
|
US4906630A
(en)
*
|
1985-11-22 |
1990-03-06 |
Rorer Pharmaceutical Corporation |
Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
|
|
US4785101A
(en)
*
|
1985-11-22 |
1988-11-15 |
Rorer Pharmaceutical Corporation |
Benzodiazinone-hydroxypyrazolyl compounds, cardiotonic compositions including the same and their uses
|
|
US4859672A
(en)
*
|
1986-10-29 |
1989-08-22 |
Rorer Pharmaceutical Corporation |
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
|
|
US5002944A
(en)
*
|
1986-10-29 |
1991-03-26 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having cardiotonic activity
|
|
JPS63181827U
(2)
*
|
1987-05-13 |
1988-11-24 |
|
|
|
DE4237656A1
(de)
*
|
1992-06-13 |
1993-12-16 |
Merck Patent Gmbh |
Benzimidazolderivate
|
|
US6162804A
(en)
*
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
CA2347939C
(en)
*
|
1998-10-23 |
2006-10-10 |
Akira Matsumori |
Composition for the treatment of rheumatism, hepatitis or pancreatitis
|
|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
|
US20030236259A1
(en)
*
|
2002-02-05 |
2003-12-25 |
Rolf Hohlweg |
Novel aryl- and heteroarylpiperazines
|
|
EP1807085B1
(en)
|
2004-09-20 |
2013-08-21 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
CA2580762A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
CA2580857A1
(en)
*
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
JP5080256B2
(ja)
*
|
2004-09-20 |
2012-11-21 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用
|
|
US7829712B2
(en)
|
2004-09-20 |
2010-11-09 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
|
|
EP2289510A1
(en)
|
2004-09-20 |
2011-03-02 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
AR051091A1
(es)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
|
AU2005286648A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
JP4714921B2
(ja)
*
|
2005-02-14 |
2011-07-06 |
トーアエイヨー株式会社 |
ピモベンダンの製造法及びその中間体
|
|
AU2006343359A1
(en)
*
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
RU2499795C2
(ru)
|
2005-07-04 |
2013-11-27 |
Хай Пойнт Фармасьютикалс, ЛЛС |
Антагонисты гистаминовых н3-рецепторов
|
|
US7816542B2
(en)
*
|
2005-08-15 |
2010-10-19 |
Irm Llc |
Compounds and compositions as TPO mimetics
|
|
SG163547A1
(en)
*
|
2006-05-29 |
2010-08-30 |
High Point Pharmaceuticals Llc |
3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
|
|
EP2014656A3
(en)
*
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
|
US20120022057A1
(en)
*
|
2009-03-18 |
2012-01-26 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
|
|
US8729263B2
(en)
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
|
EP4105208A1
(en)
*
|
2013-07-31 |
2022-12-21 |
Novartis AG |
1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions
|
|
WO2018086703A1
(en)
*
|
2016-11-11 |
2018-05-17 |
Bayer Pharma Aktiengesellschaft |
Dihydropyridazinones substituted with phenylureas
|